Version 2.77


Atomoxetine, brand name Strattera, is a nonstimulant noradrenaline uptake inhibitor and is effective in treating patients with attention-deficit hyperactivity disorder (ADHD). Atomexetine can be taken either as a daily or twice daily medication and has a low potential for abuse, which is useful for patients who have a history of substance abuse as well as patients who have comorbid anxiety or tics. It is also useful for patients who do not want to take a controlled substance as Atomexetine is not a controlled substance in the United States. Atomoxetine is rapidly absorbed, and has a high affinity and selecivity to inhibit norepinephrine uptake. It also binds to areas with high distributions of noradrenergic neurons. Common side effects of Atomoxetine are mild to moderate headache, abdominal pain, decreased appetite, vomiting, somnolence, and nausea. PMID: 18399707 Source: Regenstrief LOINC

Basic Part Properties

Part Display Name
Part Type
Component (Describes the core component or analyte measured)
Created On
Construct for LOINC Short Name

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup$lookup?system=
ConceptMap translate$translate?system=

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 托莫西汀
fr-CA French (Canada) Atomoxétine
et-EE Estonian (Estonia) Atomoksetiin
es-ES Spanish (Spain) Atomoxetina
it-IT Italian (Italy) Atomoxetina
tr-TR Turkish (Turkey) Atomoksetin
ru-RU Russian (Russian Federation) Атомоксетин
nl-NL Dutch (Netherlands) atomoxetine
fr-BE French (Belgium) Atomoxétine